Add to ORKGTrimethyllysine (TML) serves as a nutrient precursor of the gut microbiota-derived metabolite trimethylamine Noxide (TMAO) and is associated with incident cardiovascular (CV) events in stable subjects. We examined the relationship between plasma TML levels and incident CV events in patients presenting with acute coronary syndromes (ACS)
BACKGROUND: Recent studies show a mechanistic link between gut microbiota-dependent formation of the...
Background and aimsIntestinal flora metabolites are associated with cardiovascular (CV) diseases inc...
Background: Production of the proatherogenic metabolite, trimethylamine N-oxide (TMAO), from dietary...
Trimethyllysine (TML) serves as a nutrient precursor of the gut microbiota-derived metabolite trimet...
AIMS Trimethyllysine (TML) serves as a nutrient precursor of the gut microbiota-derived metaboli...
Systemic levels of trimethylamine N-oxide (TMAO), a pro-atherogenic and pro-thrombotic metabolite pr...
Aims: Systemic levels of trimethylamine N-oxide (TMAO), a pro-atherogenic and pro-thrombotic metabol...
Using an untargeted metabolomics approach in initial (N = 99 subjects) and replication cohorts (N = ...
Background and aimsIntestinal flora metabolites are associated with cardiovascular (CV) diseases inc...
AimsTo examine associations of the gut microbial metabolite trimethylamine-N-oxide (TMAO) and its pr...
To investigate the association of liver metabolite trimethylamine N-oxide (TMAO) with cardiovascular...
Background: Trimethylamine N-oxide (TMAO), a gut microbiota metabolite from dietary phosphatidylchol...
Aims Trimethyllysine (TML) is involved in carnitine synthesis, serves as a precursor of trimethylami...
Background: Recent studies show a mechanistic link between gut microbiota-dependent formation of the...
Plasma concentrations of trimethylamine N-oxide (TMAO) have been linked to cardiovascular disease (C...
BACKGROUND: Recent studies show a mechanistic link between gut microbiota-dependent formation of the...
Background and aimsIntestinal flora metabolites are associated with cardiovascular (CV) diseases inc...
Background: Production of the proatherogenic metabolite, trimethylamine N-oxide (TMAO), from dietary...
Trimethyllysine (TML) serves as a nutrient precursor of the gut microbiota-derived metabolite trimet...
AIMS Trimethyllysine (TML) serves as a nutrient precursor of the gut microbiota-derived metaboli...
Systemic levels of trimethylamine N-oxide (TMAO), a pro-atherogenic and pro-thrombotic metabolite pr...
Aims: Systemic levels of trimethylamine N-oxide (TMAO), a pro-atherogenic and pro-thrombotic metabol...
Using an untargeted metabolomics approach in initial (N = 99 subjects) and replication cohorts (N = ...
Background and aimsIntestinal flora metabolites are associated with cardiovascular (CV) diseases inc...
AimsTo examine associations of the gut microbial metabolite trimethylamine-N-oxide (TMAO) and its pr...
To investigate the association of liver metabolite trimethylamine N-oxide (TMAO) with cardiovascular...
Background: Trimethylamine N-oxide (TMAO), a gut microbiota metabolite from dietary phosphatidylchol...
Aims Trimethyllysine (TML) is involved in carnitine synthesis, serves as a precursor of trimethylami...
Background: Recent studies show a mechanistic link between gut microbiota-dependent formation of the...
Plasma concentrations of trimethylamine N-oxide (TMAO) have been linked to cardiovascular disease (C...
BACKGROUND: Recent studies show a mechanistic link between gut microbiota-dependent formation of the...
Background and aimsIntestinal flora metabolites are associated with cardiovascular (CV) diseases inc...
Background: Production of the proatherogenic metabolite, trimethylamine N-oxide (TMAO), from dietary...